Status:
RECRUITING
Advancing Dignity, Health, and Optimism in Connection With Long Acting Injectables
Lead Sponsor:
Mazonson & Santas Inc.
Collaborating Sponsors:
AIDS Healthcare Foundation
Be Well Medical Center
Conditions:
HIV
Eligibility:
All Genders
18+ years
Brief Summary
ADHOC-LA is an observational study of people living with HIV who either are taking, or have taken, a long-acting injectable therapy to manage their HIV. Data from this study will be used to research t...
Detailed Description
ADHOC-LA is an observational study that uses an online questionnaire to collect data on adults living with HIV who are currently taking, or have previously taken, long-acting injectable therapy to man...
Eligibility Criteria
Inclusion
- Eligibility Criteria:
- Have an HIV-1 infection
- a) Currently take a long-acting injectable therapy for HIV supplied by ViiV as part of a ViiV-sponsored, long-acting injectables therapy trial (LATTE-2, ATLAS-2M, CUSTOMIZE, POLAR, FLAIR, or SOLAR), or
- b) Currently take a long-acting injectable therapy for HIV prescribed by their provider, not in conjunction with a ViiV-sponsored clinical trial, or
- c) No longer taking long-acting injectable therapy for HIV, but previously received three or more injections of long-acting injectable therapy, either:
- Supplied by ViiV as part of a ViiV-sponsored, long-acting injectables therapy trial (LATTE-2, ATLAS-2M, CUSTOMIZE, POLAR, FLAIR, or SOLAR), or
- Prescribed by their provider, unrelated to a ViiV-sponsored clinical trial.
- Age 18 or above
- Have no known acute medical problem requiring immediate inpatient treatment
- Able to read and write in English
- Able and willing to provide online informed consent and to complete the online profile
- Not currently enrolled in another clinical trial in which the participant is receiving a long-acting injectable therapy for HIV.
- Participants who meet the eligibility criteria but are still receiving ViiV-supplied drug may enroll in the registry, but will not begin the online questionnaire until they are rolled off of ViiV-supplied long-acting injectable therapy.
Exclusion
Key Trial Info
Start Date :
May 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 20 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05208541
Start Date
May 20 2021
End Date
May 20 2026
Last Update
January 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mazonson & Santas Inc
Menlo Park, California, United States, 94025